E79.8
Other disorders of purine and pyrimidine metabolism
Clinical Classification Guidelines
Medical Intelligence & Overview
Disorders of purine and pyrimidine metabolism refer to a group of rare conditions that affect how the body processes these essential building blocks of DNA and RNA. These metabolic disturbances can lead to a variety of health issues, depending on the specific disorder and its severity. The ICD-10 code E79.8 is used to categorize other specified disorders of purine and pyrimidine metabolism that do not fall into more common categories. These conditions may be inherited or acquired and often require specialized diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations that alter enzymes involved in purine or pyrimidine breakdown Enzyme deficiencies affecting nucleotide metabolism Inherited metabolic syndromes Other rare genetic disorders impacting nucleotide synthesis and degradation Potential environmental factors, though less common
Key Symptoms: Growth delays and developmental issues in children Muscle weakness or fatigue Neurological problems such as seizures or developmental delays Elevated levels of purines or pyrimidines in blood or urine Signs of organ damage, especially in the liver or kidneys Unusual skin rashes or symptoms related to uric acid buildup
Diagnostic & Treatment
Diagnosis Path: Diagnosis often involves a combination of blood and urine tests to detect abnormal levels of purines or pyrimidines. Genetic testing may be used to identify specific mutations related to the disorder. Additionally, doctors might perform enzyme activity assays and imaging studies to assess organ health and rule out other conditions. A detailed medical history and clinical examination are essential components for accurate diagnosis.
Treatment Protocols: While there is no single cure for these disorders, management typically focuses on controlling symptoms and preventing complications. Approaches may include dietary modifications to reduce purine or pyrimidine intake, medications to regulate metabolic processes, and supportive therapies. Regular monitoring of blood and urine levels helps guide treatment adjustments. In some cases, enzyme replacement or gene therapy might be considered as future treatment options.
Clinical Advice & FAQs
Billing Guidance
Is E79.8 a billable ICD-10 code?
Yes, E79.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E79.8?
Clinical documentation must specify the nature of Other disorders of purine and pyrimidine metabolism and any associated comorbidities for accurate reporting.
Cite this Clinical Reference